Antibody formation against SARS-CoV-2 in imatinib-treated COVID-19 patients-Reference-Cited by-同舟云学术

Antibody formation against SARS-CoV-2 in imatinib-treated COVID-19 patients

Published:2021-08 Issue: Volume: Page:
ISSN:0163-4453
Container-title:Journal of Infection
language:en
Short-container-title:Journal of Infection

Author:

Morales-Ortega Alejandro^ORCID,Farfán-Sedano Ana Isabel,Izquierdo-Martínez Aida,Llarena-Barroso Cristina,Jaenes-Barrios Beatriz,Mesa-Plaza Nieves,Toledano-Macías María,Soria Fernández-Llamazares Guillermo,Molina-Esteban Laura,García de Tena Jaime^ORCID,Prieto-Menchero Santiago,Gonzalo-Pascua Sonia,San Martín-López Juan Víctor^ORCID,Bernal-Bello David^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical)

Reference10 articles.

1. Antibody response in individuals infected with SARS-CoV-2 early after the first dose of the BNT162b2 mRNA vaccine: SARS-CoV-2 infection early after the first vaccine dose;Gobbi;J Infect,2021

2. Early clinical experience with imatinib in COVID-19: searching for a dual effect;Morales-Ortega;J Infect,2021

3. Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial;Aman;Lancet Respir Med,2021

4. Kinase inhibitors developed for treatment of hematologic malignancies: implications for immune modulation in COVID-19;Jacobs;Blood Adv,2021

5. Chronic myeloid leukemia patients resistant to or intolerant of interferon alpha and subsequently treated with imatinib show reduced immunoglobulin levels and hypogammaglobulinemia;Steegmann;Haematologica,2003

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amuvatinib Blocks SARS-CoV-2 Infection at the Entry Step of the Viral Life Cycle;Microbiology Spectrum;2023-06-15